BetterLife Pharma (BETRF) Cash & Current Investments (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Cash & Current Investments of $20846.4 for Q2 2026, up 56.15% year-over-year from $13350.4 in Q2 2025, and up 130.15% quarter-over-quarter from $9057.6 in Q1 2026.
BetterLife Pharma (BETRF) Cash & Current Investments (2011 - 2026) Analysis & Trends
BetterLife Pharma's Cash & Current Investments history runs 16 years deep, the most recent figure standing at $20846.4 for Q2 2026.
- In Q2 2026, Cash & Current Investments rose 56.15% year-over-year to $20846.4; the TTM figure through Apr 2026 stood at $20846.4 (up 56.15% YoY), while the FY2026 annual figure was $9057.6, up 57.19% from the prior year.
- Cash & Current Investments for Q2 2026 stood at $20846.4, up from $9057.6 in the prior quarter.
- The five-year high for Cash & Current Investments was $311862.7 in Q2 2024, with the low at $5762.2 in Q1 2025.
- The 5-year median for Cash & Current Investments is $20846.4 (2026), against an average of $59097.9.
- The sharpest annual moves came in 2022 and 2023: Cash & Current Investments plunged 99.68% in 2022, then soared 1508.19% in 2023.
- BetterLife Pharma's Cash & Current Investments stood at $31362.6 in 2022, then surged by 117.79% to $68305.2 in 2023, then plunged by 79.98% to $13674.0 in 2024, then advanced by 17.96% to $16129.9 in 2025, then rose by 29.24% to $20846.4 in 2026.
- Business Quant data shows BETRF's Cash & Current Investments at $20846.4 in Q2 2026, $9057.6 in Q1 2026, and $16129.9 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.14 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3.31 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.39 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.16 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 836.99 Mn |
| 10 | BetterLife Pharma | 36.45 Mn | 36.42 Mn | - | 20,846.36 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 20,846.36 |
| Jan 31, 2026 | 9,057.56 |
| Jul 31, 2025 | 16,129.91 |
| Apr 30, 2025 | 13,350.44 |
| Jan 31, 2025 | 5,762.21 |
| Oct 31, 2024 | 13,674.03 |
| Jul 31, 2024 | 92,242.05 |
| Apr 30, 2024 | 311,862.66 |
| Jan 31, 2024 | 27,653.75 |
| Oct 31, 2023 | 68,305.21 |
| Jul 31, 2023 | 45,695.44 |
| Apr 30, 2023 | 182,895.46 |
| Jan 31, 2023 | 6,158.76 |
| Oct 31, 2022 | 31,362.61 |
| Jul 31, 2022 | 11,205.72 |
| Apr 30, 2022 | 11,372.75 |
| Jan 31, 2022 | 137,089.43 |
| Oct 31, 2021 | 1.70 Mn |
| Jul 31, 2021 | 3.46 Mn |
| Apr 30, 2021 | 218,238.01 |